Jonathan Chan

China’s first counter-sanction on US biotech industry marks a turning point in tech war https://t.co/Qj4kb8OPlg

China discovers cluster of new mpox strain | Reuters https://t.co/zzleTZ5UQl

RT @statnews: What Covid tried to teach us — and why it will matter in the next pandemic https://t.co/zkIyNDMb8V

Pharmaceutical Dealmaking Between China, West on Rise - Bloomberg https://t.co/J29EvbQ60D

https://t.co/p2I6wGBtVw

China’s new drug approvals take market scale beyond US$13 billion as innovation picks up | South China Morning Post https://t.co/32guNoFMXf

AstraZeneca stock tanks over fears of expanding China probe https://t.co/rXvAHpFAV0

Henlius, XtalPi sign deals to expand abroad as Chinese drug companies ‘go out’ for growth | South China Morning Post https://t.co/KfC5DPhJyA

Chinese pharmaceutical firms expand to Africa under ‘health silk road’ https://t.co/hpjkfdlbAV

US consumer health company Kenvue eyes innovation to tap China's growing market - https://t.co/a6pZPkB890 https://t.co/v3DuF0ic6z

Japan's spending slump eases as economy reopens, COVID-19 clouds outlook | Reuters https://t.co/4v17Bv1PWq

China's once-booming online health care sees its vital signs sink - Nikkei Asia https://t.co/FiRLUZovP6

China approves CSPC Pharma's RSV vaccine for clinical trials | Reuters https://t.co/Woppbkyymy

Novo Will Limit Wegovy’s China Launch to Avoid Global Disruption - Bloomberg https://t.co/oaoVOEtrhy

China approves CSPC Pharma mRNA cancer therapy for clinical trials | Reuters https://t.co/cNcJPgjTPm

China OKs Novo Nordisk's Type-2 diabetes treatment to enter its market | Reuters https://t.co/Z9unVFgWq2

Who Do Asia-Pacific Consumers Trust to Manage Their Healthcare? | Bain & Company https://t.co/lXLUuNYV2A